Extensively hydrolyzed whey infant formula
OtherNew hydrolyzed infant formula.
Other names: Baby Formula
NCT Number: NCT01210391
The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
Looking for future studies?
Notify Me11 day–4 month
All sexes
Interventional
Not applicable
Colorado Springs Health Partners, Colorado Springs, Colorado, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
New hydrolyzed infant formula.
Other names: Baby Formula
Commercially available infant formula.
Other names: Baby Formula
Time frame: 4 Months
Mean weight gain (g/day) from enrollment to 4 months of age.
Looking for future studies?
Notify MeSociété des Produits Nestlé (SPN)
Industry
Assessment of Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03003117
Behavior, Breast Feeding
Lille, France
View Trial DetailsNCT06312059
Growth
New York, United States
View Trial DetailsNCT04316221
Development; Delayed, Growth
Tecpán Guatemala, Departamento de Chimaltenango, Guatemala
View Trial DetailsNCT07302477
Adverse Event, Growth
Chak Four Hundred Fifty-four, Pakistan
View Trial Details